Stock listing
OTC:CBSC Cardiac Biotech Solutions Inc. Stock
Follow Cardiac Biotech Solutions Inc. into a list and get an email when it puts out news.
Share price · OTC:CBSC
$0.035 USD 0.000 (0.0%)
Close on Nov 9, 2026
- Day range
- $0.035 – $0.035 USDNov 9, 2026
- Volume
- 15,000 sharesNov 9, 2026
- Market cap
- $5.88M USDAt the close on Nov 9, 2026 · price × 170.4M shares outstanding
- 52-week range
- $0.016 – $0.063 USDLowest and highest trades, Nov 10, 2025 – Nov 9, 2026
- Traded on an average day
- $625 USDMedian day 0 shares · 36 days with no trades · last 3 months, Aug 10, 2026 – Nov 9, 2026

Daily closes
Last 3 months, Aug 10, 2026 – Nov 9, 2026 · OTC:CBSC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 15,000 | |
| $0.035 | +0.004 | +13.1% | $0.035 | $0.035 | $0.035 | 4,994 | |
| $0.031 | +0.000 | +0.7% | $0.031 | $0.031 | $0.031 | 11,300 | |
| $0.030 | -0.003 | -8.2% | $0.035 | $0.035 | $0.030 | 102,000 | |
| $0.033 | 0.000 | 0.0% | $0.033 | $0.033 | $0.033 | 0 | |
| $0.033 | 0.000 | 0.0% | $0.033 | $0.033 | $0.033 | 0 | |
| $0.033 | 0.000 | 0.0% | $0.033 | $0.033 | $0.033 | 0 | |
| $0.033 | -0.003 | -8.3% | $0.033 | $0.033 | $0.033 | 15,000 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | +0.001 | +2.9% | $0.035 | $0.036 | $0.035 | 14,200 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.000 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | +0.004 | +12.9% | $0.035 | $0.035 | $0.035 | 63,300 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.031 | $0.031 | 0 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.031 | $0.031 | 0 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.031 | $0.031 | 0 | |
| $0.031 | 0.000 | 0.0% | $0.031 | $0.031 | $0.031 | 0 | |
| $0.031 | -0.005 | -13.9% | $0.039 | $0.039 | $0.030 | 520,700 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 30,000 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 2,000 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 300 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 30,000 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | -0.004 | -10.0% | $0.036 | $0.036 | $0.036 | 1,000 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 10,000 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 0 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 0 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 0 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 0 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 100,000 | |
| $0.040 | +0.002 | +5.3% | $0.040 | $0.040 | $0.036 | 99,300 | |
| $0.038 | +0.002 | +5.6% | $0.038 | $0.038 | $0.038 | 10,700 | |
| $0.036 | 0.000 | 0.0% | $0.036 | $0.036 | $0.036 | 0 | |
| $0.036 | +0.003 | +9.1% | $0.040 | $0.040 | $0.036 | 22,300 | |
| $0.033 | 0.000 | 0.0% | $0.033 | $0.033 | $0.033 | 100 | |
| $0.033 | 0.000 | 0.0% | $0.033 | $0.033 | $0.033 | 0 | |
| $0.033 | -0.004 | -10.8% | $0.035 | $0.035 | $0.033 | 200 | |
| $0.037 | +0.013 | +54.2% | $0.035 | $0.037 | $0.035 | 23,400 | |
| $0.024 | 0.000 | 0.0% | $0.024 | $0.024 | $0.024 | 0 | |
| $0.024 | 0.000 | 0.0% | $0.024 | $0.024 | $0.024 | 0 | |
| $0.024 | -0.006 | -20.0% | $0.024 | $0.024 | $0.024 | 100 |
Splits
3 splits since 1997 · OTC:CBSC · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-75 | Consolidation | |
| 1-for-5 | Consolidation | |
| 2-for-1 | Split |
- Ticker
- OTC:CBSC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Jan 15, 2026
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
Latest news
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
Jan 15, 2026
Closed $0.029 (-12.1%) on Jan 15, 2026
Cardiac Biotech Solutions Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 1 in the last 12 months · 47 in all · newest Jan 15, 2026 · oldest 2016
Valuation
EV/sales 43.3× against a median of 0.4×: 5th lowest of 6 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 9, 2026
- Enterprise value
- $6.41M USD
- P/E
- Loss
- EV/sales
- 43.3×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- Not reported
- Operating margin
- −725.5%
- Net margin
- −578.0%
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.36
Medical devices & supplies: the 10 companies nearest in size, of 449 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cardiac Biotech Solutions Inc. · OTC:CBSC | US$5.88M | US$6.41M | n/a | 43.3× | n/a | n/a | −578.0% | n/a | 0.36 |
| Airway Medix SA · GPW:AWM | US$6.73M | US$10.07M | n/a | 278× | n/a | n/a | n/a | n/a | n/a |
| Surgical Innovations Group plc · LSE:SUN | US$6.71M | US$7.01M | n/a | 0.5× | n/a | 0.7× | −7.7% | 0.1× | n/a |
| Izotropic Corp. · CSE:IZO | US$6.30M | US$6.26M | n/a | n/a | n/a | n/a | n/a | n/a | 0.21 |
| Accuray Incorporated · NASDAQ:ARAY | US$6.20M | US$65.61M | n/a | 0.2× | n/a | 0.1× | −4.4% | 1.9× | 2.46 |
| NeuroOne Medical Technologies Corporation · NASDAQ:NMTC | US$5.94M | US$3.89M | n/a | 0.4× | n/a | 1.6× | −78.6% | 0.0× | 1.07 |
| Neola Medical AB · OMXSTO:NEOLA | US$5.46M | US$5.06M | n/a | n/a | n/a | 0.6× | n/a | 0.0× | n/a |
| ENDRA Life Sciences Inc. · NASDAQ:NDRA | US$5.36M | US$3.85M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | 1.07 |
| MEKICS Co., Ltd. · KRX:058110 | US$5.26M | US$2.05M | 6.6× | 0.2× | 1.3× | 0.2× | 7.7% | 0.1× | n/a |
| PT Hetzer Medical Indonesia Tbk · IDX:MEDS | US$5.13M | US$5.42M | n/a | n/a | n/a | 1.8× | n/a | 0.1× | n/a |
| Regentis Biomaterials Ltd. · AMEX:RGNT | US$5.05M | −US$3.90M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.00 |
| Median of the others | US$5.70M | US$5.24M | 6.6× | 0.4× | 1.3× | 0.7× | −6.1% | 0.0× | 1.07 |
Team and board
Officers
| Officer | Role |
|---|---|
| Charles K Martin | Chief Executive Officer, President and Director |
| William Griffin Thomas | Chief Financial Officer and Treasurer |
Board
| Director | Role |
|---|---|
| Paul K Danner | Chairman of the Board of Directors and Independent Director |
| Charles K Martin | Chief Executive Officer, President and Director |
| James E Ott | Independent Director |
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 152.7K | 41.4K | 135.1K | 82.4K | 75.6K | 32.4K | 121.9K | 58.7K | 36.6K | 33.0K |
| Cost of revenue | 0 | 0 | 42.2K | 149.2K | 9.81K | 720.0K | 43.8K | 414.7K | 227.3K | |
| Gross profit | 41.4K | 135.1K | 40.2K | -73.7K | 22.6K | -598.1K | 14.8K | -378.0K | -194.4K | |
| Research and development | 27.5K | 173.2K | 419.7K | 485.0K | 0 | 0 | ||||
| Selling, general and administrative | 1.20M | 1.31M | 2.14M | 1.80M | 2.96M | 89 | 160 | |||
| Operating income | -1.16M | -1.33M | -1.60M | -2.10M | -1.87M | -2.94M | -999.5K | -62.6K | -481.4K | -369.8K |
| Depreciation and amortization | 29.3K | 0 | 611 | 6.75K | 171.9K | 3.02K | 3.33K | 481 | ||
| EBITDA | -1.57M | -2.10M | -1.87M | -2.94M | -827.6K | -59.5K | -478.1K | -369.3K | ||
| Interest expense | 252.9K | 222.4K | 5.29K | 5.21K | 1.54M | 344.3K | 0 | 0 | ||
| Income before tax | -896.0K | -1.68M | -1.63M | -2.11M | -6.34M | -4.33M | -999.5K | -62.6K | -1.13M | -386.0K |
| Income tax | -227.9K | 1.54M | 344.3K | -171.9K | -4 | -5 | -1 | |||
| Net income | -896.0K | -1.68M | -1.63M | -2.11M | -6.34M | -4.33M | -999.5K | -62.6K | -1.13M | -386.0K |
| Earnings per share, basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.07 | -0.06 | -0.02 | -0.00 | -0.02 | -0.01 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.86K | 50.0K | 126.0K | 136.5K | 427.0K | 18.7K | 15.0K | 7.59K | 4.67K | 12.5K |
| Short-term investments | 0 | 0 | ||||||||
| Receivables | 88.4K | 6.50K | 4.68K | 3.85K | 91.6K | 13.2K | 12.7K | 11.3K | 10.8K | 6.88K |
| Inventory | 160.8K | 27.9K | 27.9K | 23.4K | 9.27K | 154.3K | 80.9K | 13.1K | 14.8K | 22.8K |
| Current assets | 494.1K | 92.4K | 175.4K | 179.8K | 529.0K | 311.2K | 108.6K | 31.9K | 30.3K | 42.1K |
| Property, plant and equipment | 5.40K | 885 | ||||||||
| Goodwill | 0 | 0 | ||||||||
| Total assets | 494.1K | 167.4K | 300.4K | 304.8K | 654.0K | 311.8K | 108.6K | 36.0K | 60.6K | 67.6K |
| Accounts payable | 230.4K | 73.8K | 32.6K | 24.0K | 9.77K | 9.21K | 13.6K | 99.9K | 149.2K | 148.4K |
| Current liabilities | 2.22M | 2.02M | 825.8K | 681.7K | 164.8K | 496.6K | 275.5K | 1.07M | 1.27M | 585.8K |
| Long-term debt | 5.10K | 0 | 0 | |||||||
| Total debt | 537.5K | 263.1K | 20.9K | 100.0K | 43.8K | 388.8K | 1.80M | 356.8K | 513.9K | 246.3K |
| Total liabilities | 2.79M | 2.12M | 943.2K | 681.7K | 164.8K | 501.7K | 2.08M | 1.07M | 1.27M | 585.8K |
| Shareholders' equity | -2.29M | -1.96M | -642.8K | -376.9K | 489.1K | -189.9K | -1.97M | -1.03M | -1.21M | -518.1K |
| Shares outstanding | 164.7M | 158.8M | 139.6M | 119.1M | 91.2M | 77.9M | 58.6M | 58.0M | 58.0M | 57.1M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -636.7K | -1.25M | -1.19M | -786.0K | -662.6K | -682.7K | -108.7K | -768.7K | -62.5K | |
| Capital spending | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | -6.35K | -535 |
| Free cash flow | -636.7K | -1.25M | -1.19M | -786.0K | -662.6K | -682.7K | -108.7K | -775.1K | -63.0K | |
| Cash from investing | 40.0K | -40.0K | -125.0K | 24.3K | -6.35K | -535 | ||||
| Cash from financing | 590.5K | 1.24M | 856.5K | 1.23M | 791.3K | 600.2K | 87.3K | 767.3K | 75.7K | |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | 0 | 0 | ||||||||
| Change in cash | -46.2K | -10.4K | -290.5K | 408.3K | 3.75K | 7.37K | 2.93K | -7.83K | 12.7K |
Cap table
Built by 6ix from Cardiac Biotech Solutions Inc.’s releases
- Common shares
- 170,438,574
- Fully diluted
- 170,438,574
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 170,438,574 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 170,438,574 |
Log in to ask 6ix AI your own questions about Cardiac Biotech Solutions Inc.